辻本 雅之

Risk Factors for Infusion Reactions in Patients with Breast Cancer Administered Trastuzumab Therapy. 

Biological & pharmaceutical bulletin 46(7) 964-968 2023年  

Incidence and risk factors of infusion reactions in patients with breast cancer administered trastuzumab plus pertuzumab-based regimen 

Cancer Chemotherapy and Pharmacology 91(1) 25-31 2023年1月  

Research on the relationship between serum indoxyl sulfate concentration and iron dynamics index in patients with end-stage kidney disease: a cross-sectional study 

Renal Replacement Therapy 8(1) 2022年11月12日  

Optimal Sampling Strategy and Threshold of Serum Vancomycin Concentration in Elderly Japanese Patients undergoing High-flux Hemodialysis 

Therapeutic Drug Monitoring 44(3) 396-403 2022年8月  査読有り

In Vitro Evidence of Potential Interactions between CYP2C8 and Candesartan Acyl-β-D-glucuronide in the Liver. 

Drug metabolism and disposition: the biological fate of chemicals 49(4) 289-297 2021年4月  査読有り責任著者

ニューモシスチス肺炎予防のST合剤による血清クレアチニン値およびカリウム値の変動に腎機能が及ぼす影響 

日本腎臓病薬物療法学会誌 9(3) 363-370 2020年12月  

A case of idiosyncratic liver injury after oxaliplatin-induced thrombocytopenia. 

Journal of clinical pharmacy and therapeutics 45(2) 373-375 2020年4月  査読有り

Factors Associated with Dose Modification of Lenalidomide Plus Dexamethasone Therapy in Multiple Myeloma. 

Biological & pharmaceutical bulletin 43(8) 1253-1258 2020年  査読有り

Uremic serum residue decreases SN-38 sensitivity through suppression of organic anion transporter polypeptide 2B1 in LS-180 colon cancer cells. 

Scientific reports 9(1) 15464-15464 2019年10月29日  査読有り責任著者

Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1. 

Xenobiotica; the fate of foreign compounds in biological systems 48(10) 1059-1071 2018年10月  査読有り

Effects of Uremic Serum Residue on OATP1B1- and OATP1B3-Mediated Pravastatin Uptake in OATP-Expressing HEK293 Cells and Human Hepatocytes. 

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 23(2) 126-132 2018年10月  査読有り責任著者

Acceleration of carboxylesterase-mediated activation of irinotecan to SN-38 by serum from patients with end-stage kidney disease 

Cancer Chemotherapy and Pharmacology 81(6) 1121-1128 2018年6月1日  査読有り

Evaluation of trace elements in augmentation of statin-induced cytotoxicity in uremic serum-exposed human rhabdomyosarcoma cells 

Toxins 10(2) 2018年2月1日  査読有り

Inhibitory Effects of Juices Prepared from Individual Vegetables on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells 

BIOLOGICAL & PHARMACEUTICAL BULLETIN 40(9) 1561-1565 2017年9月  査読有り

Cooperative inhibitory effects of uremic toxins and other serum components on OATP1B1-mediated transport of SN-38 

CANCER CHEMOTHERAPY AND PHARMACOLOGY 79(4) 783-789 2017年4月  査読有り責任著者

Inhibitory Effects of Vegetable Juices on CYP3A4 Activity in Recombinant CYP3A4 and LS180 Cells 

BIOLOGICAL & PHARMACEUTICAL BULLETIN 39(9) 1482-1487 2016年9月  査読有り筆頭著者責任著者

Uremic Toxins Enhance Statin-Induced Cytotoxicity in Differentiated Human Rhabdomyosarcoma Cells 

TOXINS 6(9) 2612-2625 2014年9月  査読有り責任著者

Possibility of Decrease in CYP1A2 Function in Patients With End-Stage Renal Disease 

THERAPEUTIC APHERESIS AND DIALYSIS 18(2) 174-180 2014年4月  査読有り筆頭著者責任著者

Effects of Decreased Vitamin D and Accumulated Uremic Toxin on Human CYP3A4 Activity in Patients with End-Stage Renal Disease 

TOXINS 5(8) 1475-1485 2013年8月  査読有り筆頭著者責任著者

Influence of Serum in Hemodialysis Patients on the Expression of Intestinal and Hepatic Transporters for the Excretion of Pravastatin 

THERAPEUTIC APHERESIS AND DIALYSIS 16(6) 580-587 2012年12月  査読有り筆頭著者責任著者

Inhibitory effects of uraemic toxins 3-indoxl sulfate and p-cresol on losartan metabolism in vitro 

JOURNAL OF PHARMACY AND PHARMACOLOGY 62(1) 133-138 2010年1月  査読有り筆頭著者責任著者

The Structure-Activity Correlation on the Inhibitory Effects of Flavonoids on Cytochrome P450 3A Activity 

BIOLOGICAL & PHARMACEUTICAL BULLETIN 32(4) 671-676 2009年4月  査読有り

Effects of uremic serum and uremic toxins on hepatic uptake of digoxin 

THERAPEUTIC DRUG MONITORING 30(5) 576-582 2008年10月  査読有り

Influence of SLCO1B3 Gene Polymorphism on the Pharmacokinetics of Digoxin in Terminal Renal Failure 

DRUG METABOLISM AND PHARMACOKINETICS 23(6) 406-411 2008年  査読有り筆頭著者

Possible mechanisms for the pharmacokinetic interaction between phenytoin and folinate in rats 

THERAPEUTIC DRUG MONITORING 29(4) 404-411 2007年8月  査読有り

Effects of dosing interval on the pharmacokinetic interaction between oral small spherical activated charcoal and amlodipine in humans 

JOURNAL OF CLINICAL PHARMACOLOGY 47(7) 904-908 2007年7月  査読有り

Effect of macrolide antibiotics on uptake of digoxin into rat liver 

BIOPHARMACEUTICS & DRUG DISPOSITION 28(3) 113-123 2007年4月  査読有り

Down-regulation of MDR1 by continuous exposure to cisplatin in LLC-PK1 cells. 

Cancer Therapy 5 89-96 2007年  査読有り

Effects of platinum derivatives on the function and expression of P-glycoprotein/MDR1 in LLC-PK1 cells: In the cases of carboplatin and nedaplatin 

J.Cancer Molecules 3 23-28 2007年  査読有り

Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B 

DRUG METABOLISM AND DISPOSITION 34(4) 577-582 2006年4月  査読有り

Polymorphisms and linkage disequilibrium of the OATP8 (OATP1B3) gene in Japanese subjects 

DRUG METABOLISM AND PHARMACOKINETICS 21(2) 165-169 2006年  査読有り

Functional analysis of organic cation transporter 3 expressed in human placenta 

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 315(2) 888-895 2005年11月  査読有り

Inhibitory effects of various beverages on ritodrine sulfation by recombinant human sulfotransferase isoforms SULT1A1 and SULT1A3 

PHARMACEUTICAL RESEARCH 22(8) 1406-1410 2005年8月  

Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B 

DRUG METABOLISM AND DISPOSITION 33(4) 518-523 2005年4月  

Digoxin up-regulates multidrug resistance transporter (MDR1) mRNA and simultaneously down-regulates steroid xenobiotic receptor mRNA 

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 306(1) 116-120 2003年6月  

Effects of continuous exposure to dioxin on MDR1 function and expression in Caco-2 cells 

JOURNAL OF PHARMACY AND PHARMACOLOGY 55(5) 675-681 2003年5月  

Up-regulation of MDR1 function and expression by cisplatin in LLC-PK1 cells 

BIOLOGICAL & PHARMACEUTICAL BULLETIN 26(2) 205-209 2003年2月  

Digoxin up-regulates MDR1 in human colon carcinoma Caco-2 cells 

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 292(1) 190-194 2002年3月  査読有り

Digoxin up-regulates MDRI in human colon carcinoma Caco-2 Cells 

Biochem Biophys Res Commun 292, 190-194 2002年